giant cell tumor
giant cell tumor
Explore linked clinical trials. Standard reference: MONDO:000217123 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of DCC-3014 to Evaluate the Efficacy, Safety, and Pharmacokinetics in Subjects With TGCT | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07832747 | |
| Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse type | Recruiting | Not applicable | 2026-09-14 | NCT07503821 | |
| Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor | Recruiting | Phase 2 | 2026-09-10 | NCT07499362 | |
| InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer | Barrett esophagus, Bone Diseases, Developmental, Carcinoma, Lobular, Digestive System Diseases, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Genital Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Nevus, Pigmented, Osteochondroma, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, adenocarcinoma, bone disorder, breast disorder, breast neoplasm, carcinoma, cirrhosis of liver, connective tissue neoplasm, digestive system disorder, epithelial neoplasm, esophageal disorder, fatty liver disease, female reproductive system disorder, giant cell tumor, hematologic disorder, hematopoietic and lymphoid system neoplasm, in situ carcinoma, liver disorder, lung cancer, lung disorder, lung neoplasm, melanocytic neoplasm, melanocytic nevus, metabolic dysfunction-associated steatotic liver disease, mixed epithelioid and spindle cell melanoma, musculoskeletal system disorder, neoplasm, osteochondrodysplasia, pigmented spindle cell nevus, precancerous condition, respiratory system disorder, respiratory tract neoplasm, skin disorder, uterine disorder, vulvar intraepithelial neoplasia | Recruiting | Not stated | 2026-08-17 | NCT05463796 | |
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse type | Active, not recruiting | Phase 3 | 2026-07-29 | NCT05417789 | |
| MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor | Recruiting | Not stated | 2026-07-27 | NCT07075471 | |
| Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse type | Not yet recruiting | Phase 2 | 2026-07-16 | NCT07707882 | |
| A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor | Active, not recruiting | Phase 3 | 2026-06-26 | NCT04488822 | |
| Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse type | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-25 | NCT03069469 | |
| TRACP-5b for Diagnosis and Follow-up of Giant Cell Tumor of Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Not stated | 2026-05-27 | NCT07609277 | |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, bone disorder, bone giant cell tumor, bone sarcoma, breast disorder, breast neoplasm, carcinoma, connective tissue neoplasm, dedifferentiated chondrosarcoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, giant cell tumor, gonadal disorder, histiocytoma, malignancy in giant cell tumor of bone, malignant endocrine neoplasm, musculoskeletal system disorder, neoplasm, osteosarcoma, ovarian cancer, ovarian carcinosarcoma, ovarian disorder, poorly differentiated thyroid gland carcinoma, sarcoma, skin disorder, thyroid gland squamous cell carcinoma, thyroid gland undifferentiated (anaplastic) carcinoma, triple-negative breast carcinoma, undifferentiated high grade pleomorphic sarcoma of bone, undifferentiated pleomorphic sarcoma | Active, not recruiting | Phase 2 | 2026-05-22 | NCT03449108 | |
| Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse type | Active, not recruiting | Phase 3 | 2026-05-04 | NCT05804045 | |
| Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 3 | 2026-04-22 | NCT03295981 | |
| Study of Vimseltinib for Tenosynovial Giant Cell Tumor | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse type | Active, not recruiting | Phase 3 | 2026-03-20 | NCT05059262 | |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor | Recruiting | Phase 1 | 2026-03-19 | NCT04192344 | |
| Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor | Recruiting | Phase 4 | 2026-01-05 | NCT07315841 | |
| Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 4 | 2026-01-05 | NCT07315828 | |
| PROMIS and Mobility Evaluation in Sarcoma Patients | Alzheimer disease, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, brain disorder, central nervous system disorder, cognitive disorder, connective tissue neoplasm, dementia, giant cell tumor, neoplasm, nervous system disorder, neurodegenerative disease, psychiatric disorder, sarcoma, tauopathy | Recruiting | Not stated | 2025-11-13 | NCT07227961 | |
| A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor | Recruiting | Not stated | 2025-10-06 | NCT04635111 | |
| Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Active, not recruiting | Phase 4 | 2025-10-01 | NCT04586660 | |
| Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 1 / Phase 2 | 2024-10-18 | NCT06647901 | |
| A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Not yet recruiting | Phase 3 | 2023-04-19 | NCT05813665 | |
| Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 2 | 2023-03-15 | NCT05595603 |